These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25645795)

  • 1. Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation.
    Tahir W; Hakeem A; Baker R; Ahmad N
    Transplant Proc; 2015; 47(1):151-4. PubMed ID: 25645795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse alveolar hemorrhage following alemtuzumab.
    Sachdeva A; Matuschak GM
    Chest; 2008 Jun; 133(6):1476-1478. PubMed ID: 18574290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report.
    Myro AZ; Bjerke G; Zarnovicky S; Holmøy T
    BMC Pharmacol Toxicol; 2018 Nov; 19(1):75. PubMed ID: 30454022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate.
    Tanriover B; Jaikaransingh V; MacConmara MP; Parekh JR; Levea SL; Ariyamuthu VK; Zhang S; Gao A; Ayvaci MUS; Sandikci B; Rajora N; Ahmed V; Lu CY; Mohan S; Vazquez MA
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1650-1661. PubMed ID: 27364616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial.
    Welberry Smith MP; Cherukuri A; Newstead CG; Lewington AJ; Ahmad N; Menon K; Pollard SG; Prasad P; Tibble S; Giddings E; Baker RJ
    Transplantation; 2013 Dec; 96(12):1082-8. PubMed ID: 24056618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance.
    Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation.
    Thomas PG; Woodside KJ; Lappin JA; Vaidya S; Rajaraman S; Gugliuzza KK
    Transplantation; 2007 Jun; 83(11):1509-12. PubMed ID: 17565326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alemtuzumab induction in deceased donor kidney transplantation.
    Huang E; Cho YW; Hayashi R; Bunnapradist S
    Transplantation; 2007 Oct; 84(7):821-8. PubMed ID: 17984833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of three induction therapies on patients with delayed graft function after kidney transplantation.
    Umber A; Killackey M; Paramesh A; Liu Y; Qin H; Atiq M; Lee B; Alper AB; Simon E; Buell J; Zhang R
    J Nephrol; 2017 Apr; 30(2):289-295. PubMed ID: 27062485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse alveolar hemorrhage and acute respiratory distress syndrome during treatment of rheumatoid arthritis with etanercept.
    Khaja M; Menon L; Niazi M; Fuentes GD
    J Bronchology Interv Pulmonol; 2012 Jul; 19(3):228-31. PubMed ID: 23207468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-associated diffuse alveolar hemorrhage.
    Vlahakis NE; Rickman OB; Morgenthaler T
    Mayo Clin Proc; 2004 Apr; 79(4):541-5. PubMed ID: 15065619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alemtuzumab-induced simultaneous onset of autoimmune haemolytic anaemia, alveolar haemorrhage, nephropathy, and stroke: A case report.
    Alnahdi MA; Aljarba SI; Al Malik YM
    Mult Scler Relat Disord; 2020 Jun; 41():102141. PubMed ID: 32446212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse alveolar hemorrhage as a fatal adverse effect of bevacizumab: an autopsy case.
    Ikeda S; Sekine A; Kato T; Yoshida M; Ogata R; Baba T; Nagahama K; Okudela K; Ogura T
    Jpn J Clin Oncol; 2014 May; 44(5):497-500. PubMed ID: 24683198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience.
    Supe-Markovina K; Melquist JJ; Connolly D; DiCarlo HN; Waltzer WC; Fine RN; Darras FS
    Pediatr Transplant; 2014 Jun; 18(4):363-8. PubMed ID: 24712738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alemtuzumab (Campath-1H)-induced coagulopathy in renal transplantation.
    Farid SG; Barwick J; Goldsmith PJ; Ahmad N; Newstead C; Baker R
    Transplantation; 2009 Jun; 87(11):1751-2. PubMed ID: 19502974
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
    Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrofurantoin-induced pulmonary hemorrhage in a renal transplant recipient receiving immunosuppressive therapy: case report and review of the literature.
    Meyer MM; Meyer RJ
    J Urol; 1994 Sep; 152(3):938-40. PubMed ID: 8051759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
    Lü TM; Yang SL; Wu WZ; Tan JM
    Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation.
    Heilman RL; Khamash HA; Smith ML; Chakkera HA; Moss AA; Reddy KS
    Clin Transplant; 2013; 27(5):772-80. PubMed ID: 23924146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipients.
    Kirsch BM; Haidinger M; Zeyda M; Böhmig GA; Tombinsky J; Mühlbacher F; Watschinger B; Hörl WH; Säemann MD
    Transpl Immunol; 2006 Nov; 16(3-4):254-7. PubMed ID: 17138063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.